Patients were stratified according to centre , performance status , tobacco use , best response to previous EGFR tyrosine-kinase inhibitor , weight loss within the previous @ months , and ethnicity , and were then randomly allocated @:@ to oral dacomitinib @ mg once-daily or matched placebo centrally via a web-based system .